酵母酵母中免疫抑制剂拉帕素的细胞循环停止的目标
概括
免疫抑制药物FK506和拉巴胺是FKBP的向蛋白轮酶. 一个复杂的FKBP和拉巴胺是有毒的,抑制酵母细胞循环的进展.
科学领域:
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
背景情况:
- FK506和拉巴胺是免疫抑制化合物,通过信号转导抑制T细胞激活.
- 这两种药物都在体外结合并抑制FK506结合蛋白 (FKBP) 轮酶.
- 拉巴胺会导致Saccharomyces cerevisiae中不可逆转的G1阶段细胞循环停止.
研究的目的:
- 为了阐明拉巴辛在Saccharomyces cerevisiae中毒性的机制.
- 为了识别参与拉帕素作用的细胞组件.
- 为了研究FKBP,FK506和拉帕米辛之间的相互作用.
主要方法:
- 在Saccharomyces cerevisiae中对拉帕素耐药性的遗传分析.
- 关于FKBP林旋转酶突变的特征.
- 调查药物相互作用 (拉帕素毒性的FK506对抗性).
主要成果:
- 缺少FKBP林旋转酶 (编码为FPR1) 的菌株是可行的,并且耐拉巴胺素,这表明FKBP对毒性至关重要.
- 一个FKBP-拉帕米辛复合体被确定为毒剂.
- 两种新基因TOR1和TOR2被确定为对拉巴胺毒性至关重要的基因,与FPR1.1相互作用.
结论:
- FKBP-拉帕米辛复合体是负责细胞循环停止的有毒实体.
- 在FKBP中,林旋转酶,TOR1和TOR2产物可能形成参与细胞循环调节的蛋白质复合体.
- 这种复合物可能会调解细胞循环进展的信号传导.
相关概念视频
Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...


